Literature DB >> 17043788

[Defect of the femoral condyle in the knee after patellectomy. Long-term results of fresh massive osteochondral allografting].

R Hart1, V Stipcák, B Kucera, I Cizmár, J Pilný.   

Abstract

The presence of a massive full-thickness osteochondral defect in the knee of young and active individuals is an unsolved problem in orthopedic surgery, especially in post-traumatic large bone defects. Fresh massive osteochondral allografts have been used for many years but mostly in oncology but not in post-traumatic cases. This case report describes a 20-year-old right leg-dominant woman, who, at age 19, sustained open Gustilo-Anderson type III comminuted fractures of the left patella and lateral femoral condyle in a motorbike accident. Initial treatment included immediate débridement and patellectomy with lavage. The large defect of the femoral condyle was reconstructed with a massive osteochondral allograft 1 year after the injury. The graft was obtained from our institutional tissue bank. The damaged bearing part of the condyle was resected to bleeding bone to create the nearly rectangular defect. The central condyle wall remained intact. The graft was trimmed to fit the defect and fixed with three cancellous 6.5-mm screws. The meniscus was not damaged. Partial weight bearing was permitted at 8 weeks and full weight bearing at 16 weeks after the surgery. At the last follow-up control 10 years after the surgery, no evidence of tibiofemoral arthrosis was present. The allograft-host interface was not visible. The radiodensity of the graft was nearly identical to the host bone. The Lysholm score and clinical findings were identical (100 points) to those 18 months after the surgery. The patient was extremely satisfied without complaints at 30 years of age.

Entities:  

Mesh:

Year:  2007        PMID: 17043788     DOI: 10.1007/s00113-006-1167-5

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  9 in total

1.  [Mosaicplasty in treatment of deep chondral knee defects - first experience.].

Authors:  P Visna; J Adler; V Pokorný; J Selucký; L Pasa
Journal:  Acta Chir Orthop Traumatol Cech       Date:  1999       Impact factor: 0.531

2.  Allograft replacement of all or part of the end of a long bone following excision of a tumor.

Authors:  F F Parrish
Journal:  J Bone Joint Surg Am       Date:  1973-01       Impact factor: 5.284

3.  Fresh small-fragment osteochondral allografts. Long-term follow-up study on first 100 cases.

Authors:  A G McDermott; F Langer; K P Pritzker; A E Gross
Journal:  Clin Orthop Relat Res       Date:  1985 Jul-Aug       Impact factor: 4.176

4.  Long-term followup of the use of fresh osteochondral allografts for posttraumatic knee defects.

Authors:  Allan E Gross; Nadav Shasha; Phil Aubin
Journal:  Clin Orthop Relat Res       Date:  2005-06       Impact factor: 4.176

5.  Fresh osteochondral allografts for post-traumatic osteochondral defects of the knee.

Authors:  M T Ghazavi; K P Pritzker; A M Davis; A E Gross
Journal:  J Bone Joint Surg Br       Date:  1997-11

6.  Long-term followup of fresh femoral osteochondral allografts for posttraumatic knee defects.

Authors:  P P Aubin; H K Cheah; A M Davis; A E Gross
Journal:  Clin Orthop Relat Res       Date:  2001-10       Impact factor: 4.176

7.  [Treatment of deep chondral defects of the knee using autologous chondrocytes cultured on a support--preparation of the cartilage graft].

Authors:  P Visna; L Pasa; J Adler; J Folvarský; D Horký
Journal:  Acta Chir Orthop Traumatol Cech       Date:  2003       Impact factor: 0.531

8.  Fresh osteochondral allografts for post-traumatic defects in the knee. A survivorship analysis.

Authors:  R J Beaver; M Mahomed; D Backstein; A Davis; D J Zukor; A E Gross
Journal:  J Bone Joint Surg Br       Date:  1992-01

9.  The viability of articular cartilage in fresh osteochondral allografts after clinical transplantation.

Authors:  A A Czitrom; S Keating; A E Gross
Journal:  J Bone Joint Surg Am       Date:  1990-04       Impact factor: 5.284

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.